Heather M. A. Prince

发表

Population Modeling Highlights Drug Disposition Differences Between Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in the Blood and Semen

Myron S. Cohen, J. Nelson, C. Gay, 2019, Clinical pharmacology and therapeutics.

Single and Multiple Dose Pharmacokinetics of Dolutegravir in the Genital Tract of HIV-Negative Women

A. Kashuba, C. Sykes, K. Patterson, 2013, Antiviral therapy.

Tenofovir/Emtricitabine Metabolites and Endogenous Nucleotide Exposures are associated with p16INK4a Expression in Subjects on Combination Therapy

M. Hudgens, N. Sharpless, C. Torrice, 2016, Antiviral therapy.

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

A. Peery, J. Rooney, C. Gay, 2017, The Journal of antimicrobial chemotherapy.

Differential Extracellular, but Similar Intracellular, Disposition of two Tenofovir Formulations in the Male Genital Tract

Myron S. Cohen, J. Nelson, A. Kashuba, 2019, Antiviral therapy.

Models for Predicting Effective HIV Chemoprevention in Women

E. Geller, M. Nicol, Yuri Fedoriw, 2015, Journal of acquired immune deficiency syndromes.

Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection

M. Hudgens, N. Sharpless, C. Torrice, 2016, PloS one.

Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV-Negative Men After Single and Multiple Dosing

N. Shaheen, E. Dellon, R. Madanick, 2013, Journal of acquired immune deficiency syndromes.

Effect of HIV Infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital Tract

A. Kashuba, N. White, K. Patterson, 2015, Antiviral therapy.

Pharmacokinetics of two common antiretroviral regimens in older HIV‐infected patients: a pilot study

A. Forrest, A. Corbett, C. Sykes, 2013, HIV medicine.